The “lifesaving” and easy-to-use opioid reversal agent is now available for OTC purchase in pharmacies Pharmacists and doctors have welcomed the availability of the first intranasal naloxone spray in Australia. Ready-to-use intranasal spray Nyxoid contains 1.8mg naloxone (as 2.2mg naloxone hydrochloride dihydrate) in a concentrated 0.1mL solution. It was first announced as having been registered
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.